Dynamic Contrast Evaluation of the Liver Using Gadoxetate Disodium (Eovist®) for Hepatocellular Carcinoma (HCC)
Hepatocellular carcinoma (HCC), a form of liver cancer, is the seventh most common cause of
cancer mortality in the US. The incidence rate of HCC is increasing along with the
incidence of Hepatitis B and C which are known to promote HCC. Patients have a better
prognosis (survival outlook) if HCC is found and treated at an early stage. MRI is the best
imaging modality for diagnosing HCC.
This study will compare standard MRIs and MRIs performed with a newly developed MR protocol
to determine if it is possible to more confidently diagnose HCC.
Observational Model: Cohort, Time Perspective: Prospective
Accuracy of a new MR protocol in diagnosing HCC and other liver lesions.
One day: participants will have one MRI of the liver.
Orpheus Kolokythas, MD
University of Washington
United States: Institutional Review Board